Nov 1 2011
At the recent International Lung Health Conference in Lille, France, IRIN/PlusNews spoke with Stop TB Director Mario Raviglione about the threat of drug-resistant tuberculosis (TB), its treatment and "the precarious TB funding gap," the news service writes. In the interview, Raviglione discusses the Directly Observed Treatment Short course (DOTS) approach to TB treatment, the issue of second-line TB drugs, and the future of TB funding, among other issues (10/31).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|